Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco

被引:291
作者
Katz, MH
Schwarcz, SK
Kellogg, TA
Klausner, JD
Dilley, JW
Gibson, S
McFarland, W
机构
[1] San Francisco Dept Publ Hlth, San Francisco, CA USA
[2] Univ Calif San Francisco, AIDS Hlth Project, San Francisco, CA 94143 USA
[3] Stop AIDS Project, San Francisco, CA USA
关键词
D O I
10.2105/AJPH.92.3.388
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. This study assessed the countervailing effects on HIV incidence of highly active anti-retroviral treatment (HAART) among San Francisco men who have sex with men (MSM). Methods. Behavioral risk was determined on the basis of responses to cross-sectional community interviews. HIV incidence was assessed through application of an enzyme-linked immunoassay testing strategy. Results, Use of HAART among MSM living with AIDS increased from 4% in 1995 to 54% in 1999. The percentage of MSM who reported both unprotected anal intercourse and multiple sexual partners increased from 24% in 1994 to 45% in 1999. The annual HIV incidence rate increased from 2.1% in 1996 to 4.2% in 1999 among MSM who sought anonymous HIV testing, and the rate was high (5.3%) but stable in a blinded survey of IVISM seeking sexually transmitted disease services. Conclusions. Any decrease in per contact risk of HIV transmission due to HAART use appears to have been counterbalanced or overwhelmed by increases in the number of unsafe sexual episodes.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 50 条
  • [1] [Anonymous], MORBIDITY MORTALITY
  • [2] Barroso PF, 2000, ANN INTERN MED, V133, P280, DOI 10.7326/0003-4819-133-4-200008150-00012
  • [3] A tale of two futures: HIV and antiretroviral therapy in San Francisco
    Blower, SM
    Gershengorn, HB
    Grant, RM
    [J]. SCIENCE, 2000, 287 (5453) : 650 - 654
  • [4] *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P889
  • [5] Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P773
  • [6] Centers for Disease Control and Prevention (CDC), 2001, MMWR-MORBID MORTAL W, V50, P117
  • [7] REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT
    CONNOR, EM
    SPERLING, RS
    GELBER, R
    KISELEV, P
    SCOTT, G
    OSULLIVAN, MJ
    VANDYKE, R
    BEY, M
    SHEARER, W
    JACOBSON, RL
    JIMENEZ, E
    ONEILL, E
    BAZIN, B
    DELFRAISSY, JF
    CULNANE, M
    COOMBS, R
    ELKINS, M
    MOYE, J
    STRATTON, P
    BALSLEY, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) : 1173 - 1180
  • [8] RECTAL GONORRHEA AS AN INDEPENDENT RISK FACTOR FOR HIV-INFECTION IN A COHORT OF HOMOSEXUAL MEN
    CRAIB, KJP
    MEDDINGS, DR
    STRATHDEE, SA
    HOGG, RS
    MONTANER, JSG
    OSHAUGHNESSY, MV
    SCHECHTER, MT
    [J]. GENITOURINARY MEDICINE, 1995, 71 (03): : 150 - 154
  • [9] Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA
    Cu-Uvin, S
    Caliendo, AM
    Reinert, S
    Chang, A
    Juliano-Remollino, C
    Flanigan, TP
    Mayer, KH
    Carpenter, CCJ
    [J]. AIDS, 2000, 14 (04) : 415 - 421
  • [10] Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
    Detels, R
    Muñoz, A
    McFarlane, G
    Kingsley, LA
    Margolick, JB
    Giorgi, J
    Scharager, LD
    Phair, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17): : 1497 - 1503